Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cel-Sci Corp (NY: CVM ) 1.085 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cel-Sci Corp < Previous 1 2 3 4 5 6 Next > 12 Health Care Stocks Moving In Monday's After-Market Session July 17, 2023 Via Benzinga CEL-SCI Announces Proposed Public Offering of Common Stock July 17, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Concludes Positive Meeting With U.S. FDA Concerning Multikine’s Approval for Head & Neck Cancer July 14, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Reports Phase 3 Tumor PD-L1 Biomarker Data Demonstrate Multikine’s Increased Efficacy and Points to Potential for Combination With Checkpoint Inhibitors for Head & Neck Cancer July 11, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI to Present Novel Data at AHNS 11th International Conference on Head and Neck Cancer—New Patent to Be Filed June 22, 2023 From CEL-SCI Corporation Via Business Wire Why CEL-SCI Shares Are Shooting Higher Today May 15, 2023 CEL-SCI Corporation (NYSE: CVM) announced that the latest results from its pivotal Phase 3 study of Multikine, a presurgical cancer immunotherapy, were presented at the European Society for... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 15, 2023 Via Benzinga Histopathology and Tumor Biomarker Analysis Confirm CEL-SCI’s Multikine Significantly Prolonged Overall Survival in Head & Neck Cancer—Phase 3 Data Presented at ESTRO 2023 May 15, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI Corporation Reports Second Quarter Fiscal 2023 Financial Results May 12, 2023 From CEL-SCI Corporation Via Business Wire Why BlackBerry Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket May 02, 2023 Gainers Leju Holdings Limited (NYSE: LEJU) gained 103.7% to $7.25 in pre-market trading after jumping around 97% on Monday . Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 02, 2023 We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday! Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session May 01, 2023 Via Benzinga CEL-SCI Announces $1.35 Million Underwritten Confidentially Marketed Public Offering of Common Stock April 27, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI to Pursue Canada’s Conditional Approval Pathway for Multikine in the Treatment of Head & Neck Cancer April 19, 2023 From CEL-SCI Corporation Via Business Wire CEL-SCI's Lead Head & Neck Cancer Candidate Shows 43% Survival Extension March 08, 2023 Via Benzinga CEL-SCI’s Multikine Phase 3 Cancer Study Shows 43% Survival Extension March 08, 2023 From CEL-SCI Corporation Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday March 08, 2023 We're getting into the biggest pre-market stock movers traders will want to keep an eye on Wednesday with the latest news! Via InvestorPlace CEL-SCI to Present New Phase 3 Data at European Congress on Head & Neck Oncology March 03, 2023 From CEL-SCI Corporation Via Business Wire Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session March 03, 2023 Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Via Benzinga CEL-SCI Corporation Reports First Quarter Fiscal 2023 Financial Results February 15, 2023 From CEL-SCI Corporation Via Business Wire Tesla To $250? Here Are 10 Other Price Target Changes For Thursday December 29, 2022 Morgan Stanley cut Tesla, Inc. (NASDAQ: TSLA) price target from $330 to $250. Morgan Stanley analyst Adam Jonas maintained an Overweight rating on the stock. Tesla shares rose 4.4% to $117.65 in... Via Benzinga CEL-SCI Reports Fiscal 2022 Financial Results and Clinical & Corporate Developments December 28, 2022 From CEL-SCI Corporation Via Business Wire 10-Year Phase 3 Trial Shows CEL-SCI's Multikine immunotherapy Extends Lives In Head & Neck Cancer Patients November 22, 2022 Via Benzinga CEL-SCI Corporation Issues Letter to Shareholders November 22, 2022 From CEL-SCI Corporation Via Business Wire Why Pinterest Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket October 28, 2022 Gainers Zovio Inc (NASDAQ: ZVO) rose 39.5% to $0.2449 in pre-market trading after gaining 7% on Thursday. Via Benzinga CEL-SCI’S Multikine Reduced 5-year Death Rate From 54% to 22% in Phase 3 Study Patients Who Were Early Tumor Responders Prior to Any Standard of Care Treatment October 17, 2022 From CEL-SCI Corporation Via Business Wire CEL-SCI’S Phase 3 Data Presented at ESMO 2022: Neoadjuvant Multikine Achieved Groundbreaking Tumor Response & Extended Overall Survival in Locally Advanced Head and Neck Cancer September 12, 2022 From CEL-SCI Corporation Via Business Wire CEL-SCI Corporation Issues Letter to Shareholders September 07, 2022 From CEL-SCI Corporation Via Business Wire CEL-SCI Corporation Announces Phase 3 Multikine® Head and Neck Cancer Results Posted on Clinicaltrials.gov August 19, 2022 From CEL-SCI Corporation Via Business Wire This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday August 16, 2022 Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month. Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.